Founder & CEO
James
Hopper
Healthcare Executive, 25+ Years
ThermoFisher Scientific
Global Business Development & M&A, Oncology
Precision Medicine & Diagnostics
Molecular diagnostics, pharmacogenomics, health economics
GE Healthcare
Contributed to $40M Novii fetal monitor acquisition
Profile
James brings 25+ years of healthcare leadership, driving innovation, commercialization, and strategic growth across startups and global matrix organizations.
- Healthcare executive with 25+ years of experience driving growth across startups and global organizations
- Led global business development and M&A in oncology and precision medicine at ThermoFisher Scientific
- Contributed to the development of the Novii fetal monitor, a medical device acquired by GE Healthcare for $40M
- Deep expertise in molecular diagnostics, pharmacogenomics, and health economics, with a focus on innovation, commercialization, and transaction execution
Areas of Focus
Smarter Prescribing Starts Here
NavRx delivers safer care, measurable savings, and better outcomes, helping healthcare organizations save $250-$500+ per patient annually while advancing precision prescribing and improving STAR ratings.
Contact Us